Erkang Pharmaceutical disclosed its 2022 performance forecast on the evening of June 30, 2023. The company expects to realize a net profit of 45-65 million yuan in 2022, turning losses into profits compared with the same period last year, so Erkang Pharmaceutical has a good prospect.
Erkang Pharmaceutical Co., Ltd. is a participant in the formulation of industrial standards for excipients in China, an enterprise selected by the National Brand Project of Xinhua News Agency, a supporting unit for the construction of the National Pharmaceutical Accessories Engineering Technology Research Center, and a national enterprise technology center in Hunan Province.